Carl Zeiss Meditec AG
Carl Zeiss Meditec AG
Your view on CZMWY
Overview
What the company does, where it operates, and who runs it.
About Carl Zeiss Meditec AG
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Andreas Pecher
- Headquarters
- Goschwitzer Strasse 51-52, Jena, DE
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Andreas Pecher
- Headquarters
- Goschwitzer Strasse 51-52, Jena, DE
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery.
The Ophthalmic Devices segment offers products and solutions for the diagnosis and treatment of eye diseases; and systems and consumables for cataract, retinal, and refractive surgeries. It serves practicing ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers.
The Microsurgery segment offers visualization solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, dental and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany.
Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Carl Zeiss Meditec AG, and the rating behind it. CZMWY last traded at $31.27, 18.1× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Carl Zeiss Meditec AG. Starting points for Carl Zeiss Meditec AG: P/E 18.1, EPS $1.35, beta 1.44 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Carl Zeiss Meditec AG. Carl Zeiss Meditec AG does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Carl Zeiss Meditec AG. Trailing twelve-month EPS for Carl Zeiss Meditec AG stands at $1.35. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Carl Zeiss Meditec AG. Carl Zeiss Meditec AG has reported as a listed company since 2012. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Carl Zeiss Meditec AG valued side by side against its closest peers. Carl Zeiss Meditec AG is measured against Medical - Instruments & Supplies peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Carl Zeiss Meditec AG, and how their positions are changing. At a $2.74B market value, institutional positions materially move Carl Zeiss Meditec AG's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Carl Zeiss Meditec AG executives and directors. Shares of Carl Zeiss Meditec AG have traded between $29.92 and $76.28 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Carl Zeiss Meditec AG. Carl Zeiss Meditec AG is a $2.74B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Carl Zeiss Meditec AG. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Carl Zeiss Meditec AG. Coverage tracks Carl Zeiss Meditec AG within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.